13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 63 holding rows worth $1,018,174,480.
- Accession
- 0001791827-25-000002
- Filer
- CIK 1791827
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 63 entries on the cover page, a total value of $1,018,174,480 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,018,174,480 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,873,000 | $62,631,400 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 515,000 | $45,999,800 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 741,900 | $39,721,326 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 223,800 | $35,427,540 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 603,011 | $33,883,188 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 64,800 | $33,823,008 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,097,800 | $31,484,904 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 60,000 | $30,351,600 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 220,400 | $30,084,600 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,126,700 | $28,956,190 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 234,500 | $28,878,675 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 666,200 | $27,547,370 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 658,000 | $26,089,700 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,358,000 | $26,032,860 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 170,000 | $25,489,800 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 318,000 | $24,730,860 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 44,600 | $23,202,258 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 89,200 | $22,630,932 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 500,000 | $20,115,000 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 947,000 | $19,953,290 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,500,000 | $19,830,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,165,800 | $19,527,150 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 446,200 | $19,516,788 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 474,000 | $18,580,800 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 137,000 | $17,293,510 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 232,800 | $16,072,512 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 188,000 | $15,906,680 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 176,600 | $15,403,052 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 67,000 | $15,379,850 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 352,000 | $14,808,640 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 109,700 | $14,659,211 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 80,700 | $14,340,390 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 700,000 | $13,419,000 | dollars as filed | call |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,053,300 | $13,239,981 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 215,000 | $12,160,400 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 192,400 | $11,996,140 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,390,100 | $11,287,612 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 514,200 | $10,885,614 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,265,200 | $10,210,164 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 354,000 | $9,097,800 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 129,600 | $8,951,472 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 2,694,600 | $8,595,774 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 62,000 | $8,535,540 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 222,900 | $8,325,315 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 97,000 | $8,101,440 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 7,966,400 | $7,966,400 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,477,200 | $7,851,060 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 352,124 | $6,827,684 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 8,400 | $5,983,572 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 76,300 | $4,472,706 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 100,000 | $4,229,000 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 532,000 | $4,112,360 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 222,000 | $3,920,520 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 502,600 | $3,377,472 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 210,000 | $3,324,300 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 82,000 | $2,281,240 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 96,000 | $2,261,760 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 287,104 | $2,239,411 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 150,000 | $1,590,000 | dollars as filed | call |
| SCYNEXIS INC | 811292200 | COM NEW | 1,228,910 | $1,486,981 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 2,018,500 | $1,365,112 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,188,178 | $1,045,597 | dollars as filed | |
| BLUEBIRD BIO INC COM NEW | 09609G209 | Stock | 81,555 | $680,169 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-25-000002 | this filing | 2025-02-14 | acceptance time not in the bulk data set |